Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
In the context of Saxagliptin & Type 2 Diabetes (T2D), saxagliptin was approved by the FDA in 2009 to aid in glycemic control for adults with type 2 diabetes, alongside diet and exercise. It can be used as monotherapy when metformin is unsuitable or in combination with other oral antidiabetics or insulin.
Onglyza | European Medicines Agency (EMA)
The European Commission approved saxagliptin in 2009 for adults with type 2 diabetes to enhance gl…